As UnitedHealth racks up unprecedented profits, the people it insures battle for care.
Medicare
Company Behind Joe Namath Medicare Advantage Ads Has Long Rap Sheet of Misconduct
The firm formerly known as Benefytt pocketed millions selling sham insurance to seniors and other consumers.
Bernie Sanders Isn’t Thankful for High Drug Prices
Another in a series of hearings with pharma CEOs takes place today.
Casualties of a Failed Health Care System
Why even an elite Boston hospital can feel like a makeshift infirmary in a war zone
The Great Medicare Advantage Marketing Scam
How for-profit health insurers convince seniors to enroll in private Medicare plans
Democrats Could Score Big by Blocking This Revolver
Demetrios Kouzoukas’s nomination battle offers the perfect opportunity for Democrats to prove themselves to voters.
Euthanize This (Merger)
The merger of Cigna and Humana, America’s fifth- and sixth-largest for-profit health insurers, would create a monster middleman to ‘compete’ with the undisputed giant, UnitedHealth.
The Medicare Advantage Trap
In 46 states, once you choose Medicare Advantage at 65, you can almost never leave.
We May Not Negotiate Prices for Ten Drugs After All
Rules that exempt drugs from Medicare negotiation if there’s ‘meaningful’ generic competition could whittle down the effect of the program.
Medicare Price Negotiation: Ten Drugs That Made the List, and Ten That Should Have
Advocates were thrilled that Medicare will negotiate the price of several insulins. But other high-profit drugs are protected by the new program’s rules.
